Case Report: Fecal Microbiota Transplantation for the Treatment of Generalized Eczema Occurring After COVID-19 Vaccination

References

• Suaini NH, Siah KT, Tham EH. Role of the gut–skin axis in IgE-mediated food allergy and atopic diseases. Curr Opin Gastroenterol. 2021;37(6):557–564. doi:10.1097/MOG.0000000000000780
   PubMed Web of Science ®Google Scholar
• Grice EA, Kong HH, Renaud G, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18(7):1043–1050. doi:10.1101/gr.075549.107
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang F, Qin W, et al. ”Gut-skin” axis: understanding psoriasis from the gut. Int J Pharm Sci. 2021;76(11):523–527.
   Google Scholar
• Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018;9:1459.
   PubMed Web of Science ®Google Scholar
• Thye AY, Bah YR, Law JW, et al. Gut–skin axis: unravelling the connection between the gut microbiome and psoriasis. Biomedicines. 2022;105:1037.
   Google Scholar
• De Pessemier B. Gut–skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms. 2021;2:353.
   Google Scholar
• Alam M. Manipulating microbiota to treat atopic dermatitis: functions and therapies. Pathogens. 2022;6:642.
   Google Scholar
• Stec A, Sikora M, Maciejewska M, et al. Bacterial metabolites: a link between gut microbiota and dermatological diseases. Int J Mol Sci. 2023;4:3494.
   Google Scholar
• Alliance CM; Microecology Committee of Shanghai Preventive Medicine Association. Chinese experts consensus on standardized methodology and clinical application of fecal microbiota transplantation. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(Z1):5–13.
   PubMedGoogle Scholar
• Català A, Muñoz-Santos C, Galván-Casas C, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2022;186(1):142–152.
   PubMed Web of Science ®Google Scholar
• Li Y, Fan L, Mao Q, et al. Clinical observation and analysis of skin reactions caused by COVID‐19 vaccination. Dermatologic Therapy. 2022;35(10):e15746.
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Barbarot S, Bieber T, et al. Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682.
   PubMed Web of Science ®Google Scholar
• Chan S. Biologics in atopic dermatitis. Curr Opin Allergy Clin Immunol. 1970;3:297–302.
   Google Scholar
• FDA Approves Dupixent® (Dupilumab) For Moderate-To-Severe Atopic Dermatitis In AdolescENTS. Available from: https://investor.regeneron.com/news-releases/news-release-details/fda-approves-dupixentr-dupilumab-moderate-severe-atopic. Accessed September 27, 2023.
   Google Scholar
• FDA Approves Pfizer’s Supplemental New Drug Application for CIBINQO® (abrocitinib). Available from: https://www.pfizer.com/news/press-release/press-release-detail/fda-approves-pfizers-supplemental-new-drug-application. Accessed September 27, 2023.
   Google Scholar
• Navarro-López V, Martínez-Andrés A, Ramírez-Boscá A, et al. Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial. Acta Dermato Venereol. 2019;99(12):1078–1084.
   PubMed Web of Science ®Google Scholar
• Navarro-López V, Ramírez-Boscá A, Ramón-Vidal D, et al. Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2018;154(1):37–43.
   PubMed Web of Science ®Google Scholar
• Huang HL, Xu HM, Liu YD, et al. Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis. J Dermatol. 2021;48(12):e574–6.
   PubMed Web of Science ®Google Scholar
• Mashiah J, Karady T, Fliss‐Isakov N, et al. Clinical efficacy of fecal microbial transplantation treatment in adults with moderate‐to‐severe atopic dermatitis. Immun Inflamm Dis. 2022;10(3):e570.
   PubMed Web of Science ®Google Scholar
• Abdel-Gadir A, Stephen-Victor E, Gerber GK, et al. Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy. Nature Med. 2019;25(7):1164–1174.
   PubMed Web of Science ®Google Scholar
• Zhang X, Shi L, Sun T, Guo K, Geng S. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol. 2021;21(1):1.
   PubMed Web of Science ®Google Scholar
• Phungviwatnikul T, Lee AH, Belchik SE, Suchodolski JS, Swanson KS. Weight loss and high-protein, high-fiber diet consumption impact blood metabolite profiles, body composition, voluntary physical activity, fecal microbiota, and fecal metabolites of adult dogs. J Anim Sci. 2022;100(2):skab379.
   PubMed Web of Science ®Google Scholar
• Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The controversial role of human gut lachnospiraceae. Microorganisms. 2020;8(4):573.
   PubMed Web of Science ®Google Scholar
• Liu R, Peng C, Jing D, et al. Biomarkers of gut microbiota in chronic spontaneous urticaria and symptomatic dermographism. Front Cell Infect Microbiol. 2021;11:703126.
   PubMed Web of Science ®Google Scholar
• Liu R, Peng C, Jing D, et al. Identification of gut microbiota signatures in symptomatic dermographism. Exper Dermatol. 2021;30(12):1794–1799.
   PubMed Web of Science ®Google Scholar
• Rostaher A, Morsy Y, Favrot C, et al. Comparison of the gut microbiome between atopic and healthy dogs—preliminary data. Animals. 2022;12(18):2377.
   Web of Science ®Google Scholar
• Zhang X, Zhang J, Chu Z, Shi L, Geng S, Guo K. Gut microbiome alterations and functional prediction in chronic spontaneous urticaria patients. J Microbiol Biotechnol. 2021;31(5):747.
   PubMed Web of Science ®Google Scholar
• Yap GC, Loo EX, Aw M, Lu Q, Shek LP, Lee BW. Molecular analysis of infant fecal microbiota in an Asian at-risk cohort–correlates with infant and childhood eczema. BMC Res Notes. 2014;7:1–6.
   PubMedGoogle Scholar
• Gore C, Munro K, Lay C, et al. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol. 2008;121(1):135–140.
   PubMed Web of Science ®Google Scholar
• Tan L, Zhao S, Zhu W, et al. The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Exper Dermatol. 2018;27(2):144–149.
   PubMed Web of Science ®Google Scholar
• Koper M, Woźniacka A, Robak E. The intestinal microbiota in psoriasis. Adv Hygie Exper Med. 2020;74:236–246.
   Google Scholar
• Song H, Yoo Y, Hwang J, Na YC, Kim HS. Faecalibacterium prausnitzii subspecies–level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol. 2016;137(3):852–860.
   PubMed Web of Science ®Google Scholar
• Zheng H, Liang H, Wang Y, et al. Altered gut microbiota composition associated with eczema in infants. PLoS One. 2016;11(11):e0166026.
   PubMed Web of Science ®Google Scholar
• Dei-Cas I, Giliberto F, Luce L, Dopazo H, Penas-Steinhardt A. Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new psoriasis-microbiome index. Sci Rep. 2020;10(1):12754.
   PubMed Web of Science ®Google Scholar
• Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67(1):128–139.
   PubMed Web of Science ®Google Scholar